Skip to main navigation Skip to search Skip to main content

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.

Translated title of the contribution: Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
  • M.G.E.H. Lam
  • , A. Dahmane
  • , W.H.M. Stevens
  • , P.P. van Rijk
  • , J.M.H. de Klerk
  • , B.A. Zonnenberg

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCombined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
Original languageUndefined/Unknown
Pages (from-to)756-765
Number of pages10
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume35
Issue number7
Publication statusPublished - 2008

Cite this